History

2024

Nov

Daiwa held the "Daiwa International Workshop 2024" in Kyoto, Japan.

2020

Apr

Daiwa announced to support SDGs. We make efforts toward further contributions to achieving a sustainable society.

2018

Jul

Daiwa held the "BioBran International Workshop 2018" in Kyoto, Japan.

Apr

Tsukuba Plant certified to FSSC22000

2017

Mar

Daiwa was awarded with “Rising Small and Medium Enterprises 300 in 2017”

2016

Jul

Daiwa was selected for Subsidy from the Small and Medium Enterprise Agency for the Development of a New Functional Food Material

2014

Sep

Daiwa was selected for Subsidy from the Kanto Bureau of Economy, Trade and Industry for the Development of Functional Food Ingredient

Apr

Daiwa held the “BioBran International Workshop 2014” in Tokyo, Japan.

Feb

Daiwa obtained a patent for BioBran as an agent for bowel disease treatment.

2013

Oct

Daiwa was selected for Subsidy from the Small and Medium Enterprise Agency for the Development of a New Functional Food Material

Jun

Daiwa was authorized as “The Project Based on Collaboration of Primary, Secondary, and Tertiary Industry Act” by the Ministry of Agriculture, Forestry and Fisheries

Jan

Daiwa held the “NKCP Workshop 2013” in Tokyo, Japan.

2012

Jul

Global sales of BioBran spread to 50 countries.

2011

Jul

Daiwa obtained a patent (Blood-viscosity reducing agent) for NKCP in USA.

May

Daiwa obtained a patent (Blood-viscosity reducing agent) for NKCP in Hong Kong.

Apr

Daiwa launched “Kefira Plus”, a new product from “LK500” and “Kefira”.

Jan

Daiwa obtained a patent (Blood-viscosity reducing agent) for NKCP in China.

2010

Aug

Daiwa held the “BioBran Workshop 2010” in Tokyo, Japan.

2009

Dec

Global sales of NKCP spread to 20 countries.

Oct

Daiwa obtained a patent (cancer distant metastasis-suppressing agent) for NKCP in Japan. Daiwa obtained a patent (Blood-viscosity reducing agent) for NKCP in Switzerland, Germany, France and UK.

Aug

Daiwa held the “BioBran International Workshop 2009” in Tokyo, Japan.

May

Daiwa obtained a patent (Diabetes drug) for NKCP in Japan.

2008

Apr

Daiwa launched Rice Kefiran-based products, “LK500” and “Kefira”.

2007

Aug

Daiwa obtained a patent (Blood-viscosity reducing agent) for NKCP in Taiwan.

Apr

Global sales of BioBran spread to 40 countries. Daiwa obtained a patent (Blood-viscosity reducing agent) for NKCP in Korea.

2006

Jul

Daiwa held a meeting to launch “Rice Kefiran”, a new vegetable-origin functional food ingredient, in Tokyo, Japan.

Jun

Daiwa began export of Rice Kefiran.

May

Daiwa held BioBran book publication seminar in Tokyo, Japan.

2005

May

Daiwa launched new BioBran-based products, “Lentin Plus LY” and “BioBran Candy”.

2004

Sep

Daiwa established overseas affiliated company, Daiwa Health Development Inc., in Los Angeles, CA., U.S.A.

Apr

Daiwa obtained a process patent for NKCP in Japan.

Mar

Daiwa held International Seminar, “2004 General Meeting of BioBran Study Conference”, in Tokyo, Japan. Daiwa obtained a process patent for BioBran in Japan.

2003

Dec

Tsukuba Plant obtained HACCP certification.

Jul

Daiwa obtained approval from the Ministry of Health, Labor, and Welfare to label “PIOTEA Drink Powder” as a food for specified health use.

Jun

Daiwa established overseas affiliated company, SIAM DHD, in Bangkok, Thailand.

Mar

Daiwa completed expansion of the Tsukuba Plant.

2002

Dec

Daiwa obtained ISO9001 certification.

Apr

Global sales of BioBran spread to 27 countries.

2001

Nov

Daiwa began export of NKCP.

Apr

Daiwa obtained approval from the Ministry of Health, Labor, and Welfare to label “PIOTEA Drink” and “PIOTEA Roasted Powder” as a food for specified health use. Daiwa launched a NKCP-based product, “NKCP tablet”.

Feb

Daiwa held the “BioBran Study Conference 2001” in Tsukuba, Japan.

2000

Sep

Daiwa established overseas affiliated company, DHD (Europe) Ltd, in Cambridge, U.K.

Aug

Daiwa commenced research and development of Rice Kefiran, with sponsorship from the Ministry of Agriculture, Forestry, and Fisheries of Japan.

Mar

Daiwa opened the Tsukuba Plant.

1999

Oct

Daiwa began export of BioBran to the United States.

1998

May

Daiwa commenced research and development of Purified Natto Culture Filtrate (NKCP).

1997

Jul

Daiwa obtained a process patent for BioBran in 8 countries, including the U.S.

1996

Sep

Daiwa began export of BioBran to both Korea and Taiwan.

1995

Mar

Daiwa established the extraction technology of a new physiologically active substance, “MGN-3” (Rice Bran Arabinoxylan Compound), in rice bran.

1992

Apr

Daiwa commenced development in the area of functional foods. Daiwa began a cooperative study with Professor Mamdooh Ghoneum of UCLA/Drew University of Medicine and Science.

1990

Feb

Daiwa Pharmaceutical Co., Ltd. was founded. Daiwa began export of pharmaceuticals.